BY BANKERS REPORTER
The Board of Directors of Cipla Quality Chemical Industries Ltd (CiplaQCIL) has appointed Mr. Ajay Kumar Pal as Chief Executive Officer/Executive Director.
Kumar will replace Nevin Bradford who has spearheaded operations at the listed drug manufacturer since 2013. CiplaQCIL said Bradford will retire effective September 30, 2021.
Mr. Ajay Kumar Pal joined the Company in February 2020 as Chief Operating Officer. Prior to that, he was Senior Director, Head of Manufacturing Cipla South Africa.
He holds a Master of Business Administration in Management and Leadership from Nelson Mandela University – South Africa and a Bachelor of Pharmacy from the Rajiv Gandhi University of Health Sciences (RGUHS) – India.
He has over 15 years of experience in the pharmaceutical industry spreading across South Africa and India.
CiplaQCIL also announced the appointment of Dr. John Collins Kamili as Company Pharmacist/Executive Director.
Kamili holds Master of Pharmacy from the University of Pharmacy, Kharkiv – Ukraine, a Master of Science in Biotech Innovation and Regulatory Sciences from Purdue University – USA.
He is a registered member of the Pharmaceutical Society of Uganda (PSU) and the Pharmacy Board in the Ministry of Health of Uganda.
Kamili has been working with CiplaQCIL since 2009 initially as Quality Assurance Pharmacist and is currently heading the Regulatory Affairs department. He replaces Dr. Samuel Opio who left the Company on 30th April 2021.